GURUFOCUS.COM » STOCK LIST » Technology » Software » Synopsys Inc (NAS:SNPS) » Definitions » ROE %

SNPS (Synopsys) ROE % : 53.37% (As of Oct. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Synopsys ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Synopsys's annualized net income for the quarter that ended in Oct. 2024 was $4,456 Mil. Synopsys's average Total Stockholders Equity over the quarter that ended in Oct. 2024 was $8,350 Mil. Therefore, Synopsys's annualized ROE % for the quarter that ended in Oct. 2024 was 53.37%.

The historical rank and industry rank for Synopsys's ROE % or its related term are showing as below:

SNPS' s ROE % Range Over the Past 10 Years
Min: 4.22   Med: 14.43   Max: 30.86
Current: 30.86

During the past 13 years, Synopsys's highest ROE % was 30.86%. The lowest was 4.22%. And the median was 14.43%.

SNPS's ROE % is ranked better than
90.25% of 2625 companies
in the Software industry
Industry Median: 4.4 vs SNPS: 30.86

Synopsys ROE % Historical Data

The historical data trend for Synopsys's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synopsys ROE % Chart

Synopsys Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.78 14.85 18.21 21.09 29.90

Synopsys Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.08 28.03 16.90 21.96 53.37

Competitive Comparison of Synopsys's ROE %

For the Software - Infrastructure subindustry, Synopsys's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synopsys's ROE % Distribution in the Software Industry

For the Software industry and Technology sector, Synopsys's ROE % distribution charts can be found below:

* The bar in red indicates where Synopsys's ROE % falls into.



Synopsys ROE % Calculation

Synopsys's annualized ROE % for the fiscal year that ended in Oct. 2024 is calculated as

ROE %=Net Income (A: Oct. 2024 )/( (Total Stockholders Equity (A: Oct. 2023 )+Total Stockholders Equity (A: Oct. 2024 ))/ count )
=2263.38/( (6147.308+8990.702)/ 2 )
=2263.38/7569.005
=29.90 %

Synopsys's annualized ROE % for the quarter that ended in Oct. 2024 is calculated as

ROE %=Net Income (Q: Oct. 2024 )/( (Total Stockholders Equity (Q: Jul. 2024 )+Total Stockholders Equity (Q: Oct. 2024 ))/ count )
=4456.424/( (7709.396+8990.702)/ 2 )
=4456.424/8350.049
=53.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Oct. 2024) net income data. ROE % is displayed in the 30-year financial page.


Synopsys  (NAS:SNPS) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Oct. 2024 )
=Net Income/Total Stockholders Equity
=4456.424/8350.049
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(4456.424 / 6543.944)*(6543.944 / 12361.1225)*(12361.1225 / 8350.049)
=Net Margin %*Asset Turnover*Equity Multiplier
=68.1 %*0.5294*1.4804
=ROA %*Equity Multiplier
=36.05 %*1.4804
=53.37 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Oct. 2024 )
=Net Income/Total Stockholders Equity
=4456.424/8350.049
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (4456.424 / 1291.516) * (1291.516 / 1243.208) * (1243.208 / 6543.944) * (6543.944 / 12361.1225) * (12361.1225 / 8350.049)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 3.4505 * 1.0389 * 19 % * 0.5294 * 1.4804
=53.37 %

Note: The net income data used here is four times the quarterly (Oct. 2024) net income data. The Revenue data used here is four times the quarterly (Oct. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Synopsys ROE % Related Terms

Thank you for viewing the detailed overview of Synopsys's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Synopsys Business Description

Address
675 Almanor Avenue, Sunnyvale, CA, USA, 94085
Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Executives
Sassine Ghazi officer: Chief Operating Officer 3075 W RAY ROAD, SUITE 528, THE PARK AT SAN TAN, CHANDLER AZ 85226
Geus Aart De director, officer: Chairman of the Board & Co-CEO
Richard S. Mahoney officer: Chief Revenue Officer 2600 ANSYS DRIVE, CANONSBURG PA 15317
Runkel John F Jr officer: General Counsel & C/O INTUITIVE SURGICAL, INC., 1266 KIFER ROAD, SUNNYVALE CA 94086
Mercedes Johnson director MICRON TECHNOLOGY, INC, 8000 S FEDERAL WAY, MS 1-557, BOISE ID 83716
Marc N Casper director C/O THERMO FISHER SCIENTIFIC, 168 THIRD AVENUE, WALTHAM MA 02451
Roy Vallee director 2211 S 47TH ST, PHOENIX AZ 85034
Sudhindra Kankanwadi officer: VP and Corporate Controller 690 E MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Robert G Painter director C/O TRIMBLE INC., 935 STEWART DRIVE, SUNNYVALE CA 94085
Shelagh Glaser officer: CFO ZENDESK, INC., 989 MARKET STREET, SAN FRANCISCO CA 94103
Joseph W Logan officer: EVP, Sales & Corp Marketing 700 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Chrysostomos L Nikias director UNIVERSITY OF SOUTHERN CALIFORNIA, 3551 TROUSEDALE, BOVARD ADM 102, LOS ANGELES CA 90089-4019
Trac Pham officer: CFO 700 E. MIDDLEFIELD ROAD, MOUNTAIN VIEW CA 94043
Luis Borgen director 58 SUNSET RIDGE LANE, BOLTON MA 01740
Chi-foon Chan director, officer: Co-CEO & President